BridgeMD
Compares treatment options for Posterior Crossbite
Official title Leaf Expander Versus Hyrax Expander in Mixed Dentition Patients With Posterior Crossbite.
ClinicalTrials.gov ID: NCT07301918
What this study is testing
- What it's testing
- Design: Two-arm parallel randomized clinical trial in mixed dentition (6-12 years). Arms: (1) 9 mm, 900 g leaf expander; (2) 9 mm Hyrax expander.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Male and female patients
- Mixed dentition stage
- Unilateral or bilateral posterior crossbite.
- Patients in prepubertal stage with cervical vertebral maturation stage 1-3.
- Fully erupted maxillary and mandibular permanent first molars.
You likely can't join if
- Previous orthodontic treatment.
- Missing teeth.
- Inadequate oral hygiene.
- Patients with bad oral habits.
- Patients with medical conditions.
- Patients with cleft lip and palate.
See the full eligibility criteria
- Male and female patients
- Mixed dentition stage
- Unilateral or bilateral posterior crossbite.
- Patients in prepubertal stage with cervical vertebral maturation stage 1-3.
- Fully erupted maxillary and mandibular permanent first molars.
- Skeletal class I or II.
- Previous orthodontic treatment.
- Missing teeth.
- Inadequate oral hygiene.
- Patients with bad oral habits.
- Patients with medical conditions.
- Patients with cleft lip and palate.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.